XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenues $ 674,100,000 $ 620,600,000 $ 2,007,900,000 $ 1,832,200,000
Operating expenses:        
Salaries and benefits 195,000,000.0 185,500,000 592,400,000 546,300,000
Supplies 179,200,000 173,200,000 549,800,000 518,300,000
Professional and medical fees 72,400,000 68,100,000 219,900,000 198,400,000
Lease expense 21,100,000 21,600,000 64,300,000 61,800,000
Other operating expenses 40,600,000 41,000,000.0 127,600,000 116,800,000
Cost of revenues 508,300,000 489,400,000 1,554,000,000 1,441,600,000
General and administrative expenses 36,800,000 17,900,000 100,000,000.0 73,500,000
Depreciation and amortization 28,900,000 29,800,000 87,000,000.0 85,200,000
Transaction and integration costs 12,800,000 12,500,000 37,300,000 27,800,000
Grant funds 0 (500,000) (1,100,000) (1,800,000)
Net loss on disposals, consolidations and deconsolidations 5,800,000 2,200,000 7,500,000 3,200,000
Equity in earnings of unconsolidated affiliates (3,500,000) (2,400,000) (9,400,000) (8,100,000)
Litigation settlements 3,600,000 0 8,100,000 (32,800,000)
Other income, net (1,200,000) (2,400,000) (2,100,000) (7,400,000)
Total operating expenses 591,500,000 546,500,000 1,781,300,000 1,581,200,000
Operating income 82,600,000 74,100,000 226,600,000 251,000,000.0
Interest expense, net (49,800,000) (60,700,000) (144,300,000) (173,900,000)
Income before income taxes 32,800,000 13,400,000 82,300,000 77,100,000
Income tax (expense) benefit (3,100,000) (7,800,000) 6,300,000 (13,400,000)
Net income 29,700,000 5,600,000 88,600,000 63,700,000
Less: Net income attributable to non-controlling interests (34,600,000) (30,600,000) (99,500,000) (94,900,000)
Net loss attributable to Surgery Partners, Inc. $ (4,900,000) $ (25,000,000.0) $ (10,900,000) $ (31,200,000)
Net loss per share attributable to common stockholders        
Basic (in USD per share) $ (0.04) $ (0.28) $ (0.09) $ (0.35)
Diluted (in USD per share) [1] $ (0.04) $ (0.28) $ (0.09) $ (0.35)
Weighted average common shares outstanding        
Basic (shares) 125,747 88,907 125,559 88,604
Diluted (shares) [1] 125,747 88,907 125,559 88,604
[1] The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.